{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T22:27:28Z","timestamp":1777760848930,"version":"3.51.4"},"reference-count":30,"publisher":"Polish Society of Microbiologists","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Opportunistic fungal infections increase morbidity and mortality in COVID-19 patients monitored in intensive care units (ICU). As patients\u2019 hospitalization days in the ICU and intubation period increase, opportunistic infections also increase, which prolongs hospital stay days and elevates costs. The study aimed to describe the profile of fungal infections and identify the risk factors associated with mortality in COVID-19 intensive care patients. The records of 627 patients hospitalized in ICU with the diagnosis of COVID-19 were investigated from electronic health records and hospitalization files. The demographic characteristics (age, gender), the number of ICU hospitalization days and mortality rates, APACHE II scores, accompanying diseases, antibiotic-steroid treatments taken during hospitalization, and microbiological results (blood, urine, tracheal aspirate samples) of the patients were recorded. Opportunistic fungal infection was detected in 32 patients (5.10%) of 627 patients monitored in ICU with a COVID-19 diagnosis. The average APACHE II score of the patients was 28 \u00b1 6. While 25 of the patients (78.12%) died, seven (21.87%) were discharged from the ICU.\n                    <jats:italic>Candida parapsilosis<\/jats:italic>\n                    (43.7%) was the opportunistic fungal agent isolated from most blood samples taken from COVID-19 positive patients. The mortality rate of COVID-19 positive patients with candidemia was 80%. While two out of the three patients (66.6%) for whom fungi were grown from their tracheal aspirate died, one patient (33.3%) was transferred to the ward. Opportunistic fungal infections increase the mortality rate of COVID-19-positive patients. In addition to the risk factors that we cannot change, invasive procedures should be avoided, constant blood sugar regulation should be applied, and unnecessary antibiotics use should be avoided.\n                  <\/jats:p>","DOI":"10.33073\/pjm-2021-039","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T15:28:05Z","timestamp":1632065285000},"page":"395-400","source":"Crossref","is-referenced-by-count":20,"title":["Fungal Infections in COVID-19 Intensive Care Patients"],"prefix":"10.33073","volume":"70","author":[{"given":"AY\u015eENUR S\u00dcMER","family":"CO\u015eKUN","sequence":"first","affiliation":[{"name":"Antalya Kepez State Hospital , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eENAY \u00d6ZT\u00dcRK","family":"DURMAZ","sequence":"additional","affiliation":[{"name":"Antalya Kepez State Hospital , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18083","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"2026042902435827042_j_pjm-2021-039_ref_001","doi-asserted-by":"crossref","unstructured":"Al-Hatmi AMS, Mohsin J, Al-Huraizi A, Khamis F. COVID-19 associated invasive candidiasis. J Infect. 2021 Feb;82(2):e45\u2013e46. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.005","DOI":"10.1016\/j.jinf.2020.08.005"},{"key":"2026042902435827042_j_pjm-2021-039_ref_002","doi-asserted-by":"crossref","unstructured":"Armstrong-James D. Invasive Candida species infection: the importance of adequate empirical antifungal therapy. Antimicrob Chemother. 2007 Sep;60(3):459\u2013460. https:\/\/doi.org\/10.1093\/jac\/dkm260","DOI":"10.1093\/jac\/dkm260"},{"key":"2026042902435827042_j_pjm-2021-039_ref_003","doi-asserted-by":"crossref","unstructured":"Bader MS, Lai SM, Kumar V, Hinthorn D. Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality. Scand J Infect Dis. 2004;36(11\u201312):860\u2013864. https:\/\/doi.org\/10.1080\/00365540410021126","DOI":"10.1080\/00365540410021126"},{"key":"2026042902435827042_j_pjm-2021-039_ref_004","doi-asserted-by":"crossref","unstructured":"Beovi\u0107 B, Dou\u0161ak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H. Antibiotic use in patients with COVID-19: a \u2018snapshot\u2019 Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020 Nov 1;75(11):3386\u20133390. https:\/\/doi.org\/10.1093\/jac\/dkaa326","DOI":"10.1093\/jac\/dkaa326"},{"key":"2026042902435827042_j_pjm-2021-039_ref_005","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s JA, Monta\u00f1ez AM, Carre\u00f1o-Guti\u00e9rrez AM, Reyes P, G\u00f3mez CH, Pescador A, Ariza B, Rosso F. Risk factors for mortality in Colombian patients with candidemia. J Fungi (Basel). 2021 May 31;7(6):442. https:\/\/doi.org\/10.3390\/jof7060442","DOI":"10.3390\/jof7060442"},{"key":"2026042902435827042_j_pjm-2021-039_ref_006","doi-asserted-by":"crossref","unstructured":"Dupont D, Menotti J, Turc J, Miossec C, Wallet F, Richard JC, Argaud L, Paulus S, Wallon M, Ader F, et al. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Med Mycol. 2021 Jan 4;59(1):110\u2013114. https:\/\/doi.org\/10.1093\/mmy\/myaa078","DOI":"10.1093\/mmy\/myaa078"},{"key":"2026042902435827042_j_pjm-2021-039_ref_007","doi-asserted-by":"crossref","unstructured":"Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):419\u2013425. https:\/\/doi.org\/10.1007\/s10096-006-0159-2","DOI":"10.1007\/s10096-006-0159-2"},{"key":"2026042902435827042_j_pjm-2021-039_ref_008","doi-asserted-by":"crossref","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003 Nov 1;37(9): 1172\u20131177. https:\/\/doi.org\/10.1086\/378745","DOI":"10.1086\/378745"},{"key":"2026042902435827042_j_pjm-2021-039_ref_009","doi-asserted-by":"crossref","unstructured":"Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. Infect. 2009 Nov;59(5):360\u2013365. https:\/\/doi.org\/10.1016\/j.jinf.2009.08.020","DOI":"10.1016\/j.jinf.2009.08.020"},{"key":"2026042902435827042_j_pjm-2021-039_ref_010","doi-asserted-by":"crossref","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309\u2013332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002","DOI":"10.1016\/j.ajic.2008.03.002"},{"key":"2026042902435827042_j_pjm-2021-039_ref_011","doi-asserted-by":"crossref","unstructured":"Kaur H, Chakrabarti A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi (Basel). 2017 Jul 19;3(3):41. https:\/\/doi.org\/10.3390\/jof3030041","DOI":"10.3390\/jof3030041"},{"key":"2026042902435827042_j_pjm-2021-039_ref_012","doi-asserted-by":"crossref","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924","DOI":"10.1016\/j.ijantimicag.2020.105924"},{"key":"2026042902435827042_j_pjm-2021-039_ref_013","doi-asserted-by":"crossref","unstructured":"Mastrangelo A, Germinario BN, Ferrante M, Frangi C, Li Voti R, Muccini C, Ripa M; COVID-BioB Study Group. Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls. Clin Infect Dis. 2020 Oct 30:ciaa1594. https:\/\/doi.org\/10.1093\/cid\/ciaa1594","DOI":"10.1093\/cid\/ciaa1594"},{"key":"2026042902435827042_j_pjm-2021-039_ref_014","doi-asserted-by":"crossref","unstructured":"Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005 Sep;49(9):3640\u20133645. https:\/\/doi.org\/10.1128\/AAC.49.9.3640-3645.2005","DOI":"10.1128\/AAC.49.9.3640-3645.2005"},{"key":"2026042902435827042_j_pjm-2021-039_ref_015","doi-asserted-by":"crossref","unstructured":"Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, Punjabi Katiyar C, Jain R, Aldrich M, Weston G, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021 Jan;42(1):84\u201388. https:\/\/doi.org\/10.1017\/ice.2020.368","DOI":"10.1017\/ice.2020.368"},{"key":"2026042902435827042_j_pjm-2021-039_ref_016","doi-asserted-by":"crossref","unstructured":"Nucci M, Barreiros G, Guimar\u00e3es LF, Deriquehem VAS, Casti\u00f1eiras AC, Nou\u00e9r SA. Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. Mycoses. 2021 Feb;64(2):152\u2013156. https:\/\/doi.org\/10.1111\/myc.13225","DOI":"10.1111\/myc.13225"},{"key":"2026042902435827042_j_pjm-2021-039_ref_017","doi-asserted-by":"crossref","unstructured":"Obata R, Maeda T, Rizk D, Kuno T. Increased secondary infection in COVID-19 patients treated with steroids in New York City. Jpn J Infect Dis. 2021 Jul 21;74(4):307\u2013315. https:\/\/doi.org\/10.7883\/yoken.JJID.2020.884","DOI":"10.7883\/yoken.JJID.2020.884"},{"key":"2026042902435827042_j_pjm-2021-039_ref_018","doi-asserted-by":"crossref","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1\u2013e50. https:\/\/doi.org\/10.1093\/cid\/civ933","DOI":"10.1093\/cid\/civ933"},{"key":"2026042902435827042_j_pjm-2021-039_ref_019","unstructured":"Patolia S, Kennedy E, Zahir M, Patolia S, Gulati N, Narendra D, Vadde R, Pokharel S, Schmidt FM, Enriquez D, et al. Risk factors for candida blood stream infection in medical ICU and role of colonization \u2013 A retrospective study. BJMP 2013;6(2):a618"},{"key":"2026042902435827042_j_pjm-2021-039_ref_020","doi-asserted-by":"crossref","unstructured":"Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020 Dec 3;71(9):2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530","DOI":"10.1093\/cid\/ciaa530"},{"key":"2026042902435827042_j_pjm-2021-039_ref_021","doi-asserted-by":"crossref","unstructured":"Rotondo JC, Oton-Gonzalez L, Mazziotta C, Lanzillotti C, Iaquinta MR, Tognon M, Martini F. Simultaneous detection and viral DNA load quantification of different human papillomavirus types in clinical specimens by the high analytical droplet digital PCR method. Front Microbiol. 2020 Nov 19;11:591452. https:\/\/doi.org\/10.3389\/fmicb.2020.591452","DOI":"10.3389\/fmicb.2020.591452"},{"key":"2026042902435827042_j_pjm-2021-039_ref_022","doi-asserted-by":"crossref","unstructured":"Sar\u0131 S, Dal HC, Mungan \u0130, Tezcan B, Kazanc\u0131 D, Turan S. [Retrospective evaluation of non-neutropenic candidemia cases in intensive care units] (in Turkish). J Medical Surg Intensive Care Med. 2018;9(3): 74\u201377. https:\/\/doi.org\/10.5152\/dcbybd.2018.1799","DOI":"10.5152\/dcbybd.2018.1799"},{"key":"2026042902435827042_j_pjm-2021-039_ref_023","doi-asserted-by":"crossref","unstructured":"Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, et al.; Dutch-Belgian Mycosis study group. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018 Oct;6(10):782\u2013792. https:\/\/doi.org\/10.1016\/S2213-2600(18)30274-1","DOI":"10.1016\/S2213-2600(18)30274-1"},{"key":"2026042902435827042_j_pjm-2021-039_ref_024","doi-asserted-by":"crossref","unstructured":"Segrelles-Calvo G, Ara\u00fajo GRS, Llopis-Pastor E, Carrillo J, Hern\u00e1ndez-Hern\u00e1ndez M, Rey L, Rodr\u00edguez Melean N, Escribano I, Ant\u00f3n E, Zamarro C, et al. Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. Mycoses. 2021 Feb;64(2):144\u2013151. https:\/\/doi.org\/10.1111\/myc.13219","DOI":"10.1111\/myc.13219"},{"key":"2026042902435827042_j_pjm-2021-039_ref_025","doi-asserted-by":"crossref","unstructured":"Tokak S, U\u011furcan D, Tekindal MA. [Determination of candidemia risk factors in inpatients in adult intensive care unit] (in Turkish). FLORA 2020;25(1):47\u201353. https:\/\/doi.org\/10.5578\/flora.68473","DOI":"10.5578\/flora.68473"},{"key":"2026042902435827042_j_pjm-2021-039_ref_026","doi-asserted-by":"crossref","unstructured":"White PL, Dhillon R, Healy B, Wise MP, Backs M. Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures? Clin Infect Dis. 2020 Oct 18:ciaa1597. https:\/\/doi.org\/10.1093\/cid\/ciaa1597","DOI":"10.1093\/cid\/ciaa1597"},{"key":"#cr-split#-2026042902435827042_j_pjm-2021-039_ref_027.1","unstructured":"WHO. Clinical management of COVID-19: interim guidance, 27 May 2020 (No. WHO\/2019-nCoV\/clinical\/2020.5) [Internet]. Geneva (Switzerland): World Health Organization"},{"key":"#cr-split#-2026042902435827042_j_pjm-2021-039_ref_027.2","unstructured":"2020 [cited 2021 May 17]. Available from https:\/\/apps.who.int\/iris\/handle\/10665\/332196"},{"key":"2026042902435827042_j_pjm-2021-039_ref_028","doi-asserted-by":"crossref","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May; 8(5):475\u2013481. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"2026042902435827042_j_pjm-2021-039_ref_029","doi-asserted-by":"crossref","unstructured":"Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005 Nov 1;41(9):1232\u20131239. https:\/\/doi.org\/10.1086\/496922","DOI":"10.1086\/496922"}],"container-title":["Polish Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.33073\/pjm-2021-039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:05:33Z","timestamp":1777471533000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.33073\/pjm-2021-039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,17]]},"published-print":{"date-parts":[[2021,9,1]]}},"alternative-id":["10.33073\/pjm-2021-039"],"URL":"https:\/\/doi.org\/10.33073\/pjm-2021-039","relation":{},"ISSN":["2544-4646"],"issn-type":[{"value":"2544-4646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}